Skip to main content

Table 5 Summary of the eligible studies on CAR in predicting survival, treatment response, and diagnosis in patients with ovarian cancer

From: Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR

Author, Year

Conditions of participants

Significance of marker

Liu et al. [35], 2017;

Komura et al. [86], 2021

OCP: underwent surgery;

EOCP: accepted treatment

Predicting survival: OS, DSS

  1. CAR C-reactive protein-to-albumin ratio, OCP Ovarian cancer patients, EOCP Epithelial ovarian cancer patients, OS Overall survival, DSS Disease-specific survival